Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Pancreatic Neoplasms 4Neoplasms 3Multiple Myeloma 3Sarcoma 2Neoplasms, Plasma Cell 2Fatigue 1Desmoplastic Small Round Cell Tumor 1Carcinoma 1Breast Neoplasms 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

Gemcitabine 4Docetaxel 33-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2Radiotherapy 1Radiation 1Ibandronic Acid 1Grafton demineralized bone matrix gel 1Etoricoxib 1Duration of Therapy 1Drug Therapy 1Cryotherapy 1Cryosurgery 1Ascorbic Acid 1Anesthesia, Epidural 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Bone Neoplasms × Ascorbic Acid × Clear all
NCT04877587 2023-02-22

Gemcitabine With Ascorbate Including Adolescents

University of Iowa

Phase EARLY_PHASE1 Withdrawn
Sarcoma

Bone Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡